Research programme: anti-gastrin vaccine - Immunovo/Pepscan Therapeutics

Drug Profile

Research programme: anti-gastrin vaccine - Immunovo/Pepscan Therapeutics

Alternative Names: gastrin synthetic peptide antigen vaccine - Immunovo/Pepscan; Gastrine - Immunovo

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pepscan Systems
  • Developer Immunovo; Pepscan Therapeutics
  • Class Cancer vaccines
  • Mechanism of Action Gastrin 17 inhibitors; Gastrin inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Pancreatic cancer; Zollinger-Ellison syndrome

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Pancreatic-cancer in Europe (Parenteral)
  • 05 Feb 2007 Preclinical development is ongoing
  • 02 Feb 2005 Preclinical trials in Cancer in Europe (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top